Global Retirement Partners LLC Sells 239 Shares of iShares Nasdaq Biotechnology ETF (IBB)

Global Retirement Partners LLC lessened its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 5.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,781 shares of the financial services provider’s stock after selling 239 shares during the quarter. Global Retirement Partners LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $365,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $29,000. Sontag Advisory LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $32,000. Genesee Capital Advisors LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $42,000. Intercontinental Wealth Advisors LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $56,000. Finally, grace capital bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter worth about $72,000. Institutional investors and hedge funds own 65.59% of the company’s stock.

Shares of iShares Nasdaq Biotechnology ETF stock traded down $0.60 during trading hours on Friday, hitting $104.54. The company’s stock had a trading volume of 6,185,611 shares, compared to its average volume of 2,929,459. iShares Nasdaq Biotechnology ETF has a 12 month low of $89.01 and a 12 month high of $122.97.

ILLEGAL ACTIVITY NOTICE: “Global Retirement Partners LLC Sells 239 Shares of iShares Nasdaq Biotechnology ETF (IBB)” was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.baseballdailydigest.com/news/2019/04/21/global-retirement-partners-llc-has-365000-stake-in-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: Price to Earnings Ratio (PE), For Valuing Stocks

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.